Picture of Vigil Neuroscience logo

VIGL — Vigil Neuroscience News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview

Vigil Neuroscience Inc VIGL.OQ VIGL.O is expected to  show no change in quarterly revenue when it reports  results on August 1 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Vigil Neuroscience Inc is for a loss of 42 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 8 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Vigil Neuroscience Inc is $8.00, about 0.8% below its last closing price of $8.06

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-0.52-0.53-0.49Beat7.6
Dec. 31 2025-0.55-0.53-0.57Missed-7.8
Sep. 30 2024-0.53-0.54-0.47Beat13.7​
Jun. 30 2024-0.54-0.55-0.52Beat5.5
​​Mar. 31 2024-0.60-0.61-0.50Beat17.5
Dec. 31 2023-0.61-0.53-0.57Missed-6.7​
Sep. 30 2023-0.58-0.57-0.53Beat7.5
Jun. 30 2023-0.56-0.54-0.52Beat4.2
This summary was machine generated July 30 at 13:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Vigil Neuroscience

See all news